Request for proposal in support of National Institute of Allergy and Infectious Diseases (NIAID), Division of Microbiology and Infectious Diseases (DMID) Systems Serology Analyses Supporting COVAIL Trial

Frederick National Laboratory for Cancer Research (FNLCR) Operated by Leidos Biomedical Research, Inc. (Leidos Biomed) for the National Cancer Institute requires a Standalone award for Systems Serology Analyses Supporting COVAIL Trial. The FNLCR is a Government-Owned Contractor-Operated (GOCO) Federally Funded Research and Development Center (FFRDC) located at Fort Detrick, Maryland. The FNLCR partners with university, government, and corporate scientists to speed the translation of laboratory research into new diagnostic tests and treatments for cancer and AIDS. FNLCR is a multi-program laboratory currently operated by Leidos Biomedical Research Inc. (Leidos Biomed) for the National Cancer Institute (NCI) under Prime Contracts 75N91019D00024 & HHSN261201500003I. The Government assumes no liability for reimbursement for any effort or associated costs to respond, nor for any information provided as a result of this notice as no information is being requested. Please be advised that any submissions provided despite the aforementioned notice that no information is requested become Government property and will not be returned, nor will there be any ensuing discussions or debriefings of any responses. Responses submitted to this notice are not offers and cannot be accepted by the U.S. Government to form a binding contract. It is the responsibility of the interested parties to monitor this site and any sites referenced herein for additional information pertaining to business opportunities with the FNLCR, if any. Description of Work: In support of the NIAID DMID COVAIL trial, Leidos Biomed is tasked with the management, oversight, and conduct of the COVAIL trial and seeks to subcontract with a laboratory capable of successfully responding to this Statement of Work (SOW) to perform Systems Serology analyses to identify antibody features that may correlate to protective vaccine responses to SARS-CoV-2. The successful Offeror shall be tasked with developing a laboratory analysis plan detailing how they will utilize systems serology to interrogate longitudinally collected samples (serum and/or plasma) post-booster vaccination. The analysis plan will be reviewed by Leidos Biomed to ensure that it meets the stated objectives as outlined in this SOW. Upon acceptance of the analysis plan, the Subcontractor shall be tasked with receiving and analyzing the serum and/or plasma according to the stated plan. The scope of work includes multiple tasks that are to be conducted, including developing a Laboratory Analysis and Development Plan, incorporating any changes or revisions requested by Leidos Biomed, receiving and properly storing serum and/or plasma sample shipments, performing Systems Serology analyses, and reporting results. Leidos Biomedical Research, Inc. POC: To obtain a copy of the RFP please contact Maureen Wilson, Sr. Subcontracts Administrator, at [email protected]. For information concerning other opportunities with the FNLCR, please refer to: https://frederick.cancer.gov/workwithus/solicitations